629 related articles for article (PubMed ID: 26999600)
1. Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor.
MacDonald KG; Hoeppli RE; Huang Q; Gillies J; Luciani DS; Orban PC; Broady R; Levings MK
J Clin Invest; 2016 Apr; 126(4):1413-24. PubMed ID: 26999600
[TBL] [Abstract][Full Text] [Related]
2. Systematic testing and specificity mapping of alloantigen-specific chimeric antigen receptors in regulatory T cells.
Dawson NA; Lamarche C; Hoeppli RE; Bergqvist P; Fung VC; McIver E; Huang Q; Gillies J; Speck M; Orban PC; Bush JW; Mojibian M; Levings MK
JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30753169
[TBL] [Abstract][Full Text] [Related]
3. Human CD8+ Tregs expressing a MHC-specific CAR display enhanced suppression of human skin rejection and GVHD in NSG mice.
Bézie S; Charreau B; Vimond N; Lasselin J; Gérard N; Nerrière-Daguin V; Bellier-Waast F; Duteille F; Anegon I; Guillonneau C
Blood Adv; 2019 Nov; 3(22):3522-3538. PubMed ID: 31730699
[TBL] [Abstract][Full Text] [Related]
4. Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection.
Boardman DA; Philippeos C; Fruhwirth GO; Ibrahim MA; Hannen RF; Cooper D; Marelli-Berg FM; Watt FM; Lechler RI; Maher J; Smyth LA; Lombardi G
Am J Transplant; 2017 Apr; 17(4):931-943. PubMed ID: 28027623
[TBL] [Abstract][Full Text] [Related]
5. Driving allotolerance: CAR-expressing Tregs for tolerance induction in organ and stem cell transplantation.
Edinger M
J Clin Invest; 2016 Apr; 126(4):1248-50. PubMed ID: 26999608
[TBL] [Abstract][Full Text] [Related]
6. Precision Engineering of an Anti-HLA-A2 Chimeric Antigen Receptor in Regulatory T Cells for Transplant Immune Tolerance.
Muller YD; Ferreira LMR; Ronin E; Ho P; Nguyen V; Faleo G; Zhou Y; Lee K; Leung KK; Skartsis N; Kaul AM; Mulder A; Claas FHJ; Wells JA; Bluestone JA; Tang Q
Front Immunol; 2021; 12():686439. PubMed ID: 34616392
[TBL] [Abstract][Full Text] [Related]
7. Anti-HLA-A2-CAR Tregs prolong vascularized mouse heterotopic heart allograft survival.
Wagner JC; Ronin E; Ho P; Peng Y; Tang Q
Am J Transplant; 2022 Sep; 22(9):2237-2245. PubMed ID: 35434896
[TBL] [Abstract][Full Text] [Related]
8. Donor-specific chimeric antigen receptor Tregs limit rejection in naive but not sensitized allograft recipients.
Sicard A; Lamarche C; Speck M; Wong M; Rosado-Sánchez I; Blois M; Glaichenhaus N; Mojibian M; Levings MK
Am J Transplant; 2020 Jun; 20(6):1562-1573. PubMed ID: 31957209
[TBL] [Abstract][Full Text] [Related]
9. Prevention of Allograft Rejection by Use of Regulatory T Cells With an MHC-Specific Chimeric Antigen Receptor.
Noyan F; Zimmermann K; Hardtke-Wolenski M; Knoefel A; Schulde E; Geffers R; Hust M; Huehn J; Galla M; Morgan M; Jokuszies A; Manns MP; Jaeckel E
Am J Transplant; 2017 Apr; 17(4):917-930. PubMed ID: 27997080
[TBL] [Abstract][Full Text] [Related]
10. Chimeric Antigen Receptor (CAR) Regulatory T-Cells in Solid Organ Transplantation.
Gille I; Claas FHJ; Haasnoot GW; Heemskerk MHM; Heidt S
Front Immunol; 2022; 13():874157. PubMed ID: 35720402
[TBL] [Abstract][Full Text] [Related]
11. Generation of Human Alloantigen-Specific Regulatory T Cells Under Good Manufacturing Practice-Compliant Conditions for Cell Therapy.
Cheraï M; Hamel Y; Baillou C; Touil S; Guillot-Delost M; Charlotte F; Kossir L; Simonin G; Maury S; Cohen JL; Lemoine FM
Cell Transplant; 2015; 24(12):2527-40. PubMed ID: 25198125
[TBL] [Abstract][Full Text] [Related]
12. Alloantigen-specific CD4(+) regulatory T cells induced in vivo by ultraviolet irradiation after alloantigen immunization require interleukin-10 for their induction and activation, and flexibly mediate bystander immunosuppression of allograft rejection.
Hori T; Kuribayashi K; Saito K; Wang L; Torii M; Uemoto S; Kato T
Transpl Immunol; 2015 Jun; 32(3):156-63. PubMed ID: 25861842
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity.
Yamazaki S; Inaba K; Tarbell KV; Steinman RM
Immunol Rev; 2006 Aug; 212():314-29. PubMed ID: 16903923
[TBL] [Abstract][Full Text] [Related]
14. Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance.
Zhang Q; Lu W; Liang CL; Chen Y; Liu H; Qiu F; Dai Z
Front Immunol; 2018; 9():2359. PubMed ID: 30369931
[TBL] [Abstract][Full Text] [Related]
15. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts.
Giorgini A; Noble A
J Leukoc Biol; 2007 Nov; 82(5):1053-61. PubMed ID: 17684039
[TBL] [Abstract][Full Text] [Related]
16. Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes.
Tenspolde M; Zimmermann K; Weber LC; Hapke M; Lieber M; Dywicki J; Frenzel A; Hust M; Galla M; Buitrago-Molina LE; Manns MP; Jaeckel E; Hardtke-Wolenski M
J Autoimmun; 2019 Sep; 103():102289. PubMed ID: 31176558
[TBL] [Abstract][Full Text] [Related]
17. Trafficking and persistence of alloantigen-specific chimeric antigen receptor regulatory T cells in Cynomolgus macaque.
Ellis GI; Coker KE; Winn DW; Deng MZ; Shukla D; Bhoj V; Milone MC; Wang W; Liu C; Naji A; Duran-Struuck R; Riley JL
Cell Rep Med; 2022 May; 3(5):100614. PubMed ID: 35551746
[TBL] [Abstract][Full Text] [Related]
18. Functional effects of chimeric antigen receptor co-receptor signaling domains in human regulatory T cells.
Dawson NAJ; Rosado-Sánchez I; Novakovsky GE; Fung VCW; Huang Q; McIver E; Sun G; Gillies J; Speck M; Orban PC; Mojibian M; Levings MK
Sci Transl Med; 2020 Aug; 12(557):. PubMed ID: 32817364
[TBL] [Abstract][Full Text] [Related]
19. Ontak reduces the immunosuppressive tumor environment and enhances successful therapeutic vaccination in HER-2/neu-tolerant mice.
Gritzapis AD; Voutsas IF; Baxevanis CN
Cancer Immunol Immunother; 2012 Mar; 61(3):397-407. PubMed ID: 21928125
[TBL] [Abstract][Full Text] [Related]
20. Building a CAR-Treg: Going from the basic to the luxury model.
Rosado-Sánchez I; Levings MK
Cell Immunol; 2020 Dec; 358():104220. PubMed ID: 33096321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
